| The Original Profit-Taker |
| The Greatest Game on Earth or TM "Why should the billionaires have all the fun?" The ‘Game' in a nutshell Professor Smarba supplies ‘the team’. The stock market supplies the action. The experience empowers you. ___________________________________________________________________________ #1 'LIVE' Choice (September 2009) (First posted on Tuesday, September 8 2009. Based on closing prices of Friday, September 4 2009.) Human Genome Sciences 2.25% of 2012 |
Human Genome scores third and crowning goal.
Achieves a 155% annualized total.
O.K. partner, then what's our last step?
(Scroll down this page to 'The Profit-Taker Game Plan')
Place 3 new orders with your broker.
They are:
1. Cancel all previous orders.
2.Sell 25 bonds at 1742.40 each.
3.Cover all 1405 shares at $28.96.
A $4083 profit in 64 days on a $15000 investment.
A total annualized profit of !55%.
_________________________________________________________________________
In a Nutshell
__________________________________________________________________________
2009 Orders Filled Profit (Loss)
__________________________________________________________________________
September 8
25 bonds at $1217.50 each
703 common shares sold short at $19.31
(Based on our game investment of $15,000 plus an additional conservative 50% margin of
$15,000)
_______________________________________________________________________
November 2
234 shares sold short at $22.53 (234 shares sold short x $3.22 = $753.48)
Locked-in profit $753.48
_______________________________________________________________________
November 2
234 shares sold short at $25.75 (234 shares sold short at $6.44 = $1506.96)
Locked-in profit $1506.96
_______________________________________________________________________
November 11
234 shares sold short at $28.96 (234 shares sold short at $9.65 = $2258.10)
Locked-in profit $2258.10
_______________________________________________________________________
FINAL SCORE
TOTAL ANNUALIZED
'LOCKED-IN' PROFIT : 155%
(Based on our game investment of $15,000 plus a conservative 50% margin of $15,000)
_________________________________________________________________________________
THE PROFIT-TAKER GAME PLAN
Human Genome Sciences
FINAL SCORE
Common
Stock Price ($)
*28.96 Long-term Goal (Uptrend)
25.75 Sub Goal 2 (Uptrend)
22.53 Sub Goal 1 (Uptrend)
19.31 Initial Purchase Price
12.87 Sub Goal 1 (Downtrend)
6.43 Sub Goal 2 (Downtrend)
0 Long-term Goal (Downtrend)
*Underlined blue is price of last 'filled' trade.
Gamers! To verify current price, click here.
-------------------------------------------------------------------------------
Please Note Well:
In the beginning on September 8, 2009...
We bought 25 bonds. CALCULATION: $30,000 ($15,000 of which is margin) divided by
$1217.50 (price of a convertible bond) = 25 bonds.
Total investment = $30437.50
We start our plan as a half-hedge. That is, we sell short half the shares represented by our
25 bonds which equals a total of 703 shares sold short.
CALCULATION: 25 bonds x 56.23 shares per bond = 1405.75 shares. So a half-hedge is ½ of
1405 or 703 shares sold short.
Always sell short 234 shares on each move to an upside sub goal. That is, 703 shares sold
short, divided by the 3 upside sub goals = 234.
Always cover ('buy in') 234 shares on each move to a downside goal. That is, 703 shares sold
short divided by the 3 downside sub goals = 234.
__________________________________________________________________________
CONVERTIBLE BOND FACTS
Human Genome Sciences 2.25% of 2012
CONVERTIBLE PRICE : 121.75% or $1217.50
NUMBER OF SHARES: 56.23 per bond
CONVERSION VALUE : 108,58% or $1085.80
PREMIUM : 12%
MATURITY: August 15, 2012
EXCHANGE: Over-the-counter
CURRENT YIELD: 1.85%
YIELD TO MATURITY : 19.9%
ISSUE SIZE: $ 230 MILLION
CALL PRICE: No call back until August 14, 2012
Cusip: 4444903AM10
__________________________________________________________________________
UNDERLYING COMMON STOCK FACTS
Human Genome Sciences
PRICE: $19.31
HI (52 WEEKS): $22.78
LO (52 WEEKS): $0.45
VOLATILITY (%) (52 WEEKS): 116%
HI (LAST 3 MONTHS): $22.78
LO (LAST 3 MONTHS): $2.37
VOLATILITY (%) (LAST 3 MONTHS): 106%
HI (PREVIOUS 10 DAYS): $22.78
LO (PREVIOUS 10 DAYS): $16.39
VOLATILITY (%) (PREVIOUS 10 DAYS): 33.09%
EXCHANGE: NASDAQ
MARKET CAPITAL: 2.63 billion
DIVIDEND: NIL
SYMBOL: HGSI
__________________________________________________________________________
Achieves a 155% annualized total.
O.K. partner, then what's our last step?
(Scroll down this page to 'The Profit-Taker Game Plan')
Place 3 new orders with your broker.
They are:
1. Cancel all previous orders.
2.Sell 25 bonds at 1742.40 each.
3.Cover all 1405 shares at $28.96.
A $4083 profit in 64 days on a $15000 investment.
A total annualized profit of !55%.
_________________________________________________________________________
In a Nutshell
__________________________________________________________________________
2009 Orders Filled Profit (Loss)
__________________________________________________________________________
September 8
25 bonds at $1217.50 each
703 common shares sold short at $19.31
(Based on our game investment of $15,000 plus an additional conservative 50% margin of
$15,000)
_______________________________________________________________________
November 2
234 shares sold short at $22.53 (234 shares sold short x $3.22 = $753.48)
Locked-in profit $753.48
_______________________________________________________________________
November 2
234 shares sold short at $25.75 (234 shares sold short at $6.44 = $1506.96)
Locked-in profit $1506.96
_______________________________________________________________________
November 11
234 shares sold short at $28.96 (234 shares sold short at $9.65 = $2258.10)
Locked-in profit $2258.10
_______________________________________________________________________
FINAL SCORE
TOTAL ANNUALIZED
'LOCKED-IN' PROFIT : 155%
(Based on our game investment of $15,000 plus a conservative 50% margin of $15,000)
_________________________________________________________________________________
THE PROFIT-TAKER GAME PLAN
Human Genome Sciences
FINAL SCORE
Common
Stock Price ($)
*28.96 Long-term Goal (Uptrend)
25.75 Sub Goal 2 (Uptrend)
22.53 Sub Goal 1 (Uptrend)
19.31 Initial Purchase Price
12.87 Sub Goal 1 (Downtrend)
6.43 Sub Goal 2 (Downtrend)
0 Long-term Goal (Downtrend)
*Underlined blue is price of last 'filled' trade.
Gamers! To verify current price, click here.
-------------------------------------------------------------------------------
Please Note Well:
In the beginning on September 8, 2009...
We bought 25 bonds. CALCULATION: $30,000 ($15,000 of which is margin) divided by
$1217.50 (price of a convertible bond) = 25 bonds.
Total investment = $30437.50
We start our plan as a half-hedge. That is, we sell short half the shares represented by our
25 bonds which equals a total of 703 shares sold short.
CALCULATION: 25 bonds x 56.23 shares per bond = 1405.75 shares. So a half-hedge is ½ of
1405 or 703 shares sold short.
Always sell short 234 shares on each move to an upside sub goal. That is, 703 shares sold
short, divided by the 3 upside sub goals = 234.
Always cover ('buy in') 234 shares on each move to a downside goal. That is, 703 shares sold
short divided by the 3 downside sub goals = 234.
__________________________________________________________________________
CONVERTIBLE BOND FACTS
Human Genome Sciences 2.25% of 2012
CONVERTIBLE PRICE : 121.75% or $1217.50
NUMBER OF SHARES: 56.23 per bond
CONVERSION VALUE : 108,58% or $1085.80
PREMIUM : 12%
MATURITY: August 15, 2012
EXCHANGE: Over-the-counter
CURRENT YIELD: 1.85%
YIELD TO MATURITY : 19.9%
ISSUE SIZE: $ 230 MILLION
CALL PRICE: No call back until August 14, 2012
Cusip: 4444903AM10
__________________________________________________________________________
UNDERLYING COMMON STOCK FACTS
Human Genome Sciences
PRICE: $19.31
HI (52 WEEKS): $22.78
LO (52 WEEKS): $0.45
VOLATILITY (%) (52 WEEKS): 116%
HI (LAST 3 MONTHS): $22.78
LO (LAST 3 MONTHS): $2.37
VOLATILITY (%) (LAST 3 MONTHS): 106%
HI (PREVIOUS 10 DAYS): $22.78
LO (PREVIOUS 10 DAYS): $16.39
VOLATILITY (%) (PREVIOUS 10 DAYS): 33.09%
EXCHANGE: NASDAQ
MARKET CAPITAL: 2.63 billion
DIVIDEND: NIL
SYMBOL: HGSI
__________________________________________________________________________
NATURE OF BUSINESS
The mission of Human Genome Sciences is to apply science and medicine to bring
innovative drugs to patients with unmet medical needs. The Human Genome
clinical development pipeline includes novel drugs to treat hepatitis C, lupus,
inhalation anthrax and cancer.
Company Official Website: http://www.hgsi.com
The mission of Human Genome Sciences is to apply science and medicine to bring
innovative drugs to patients with unmet medical needs. The Human Genome
clinical development pipeline includes novel drugs to treat hepatitis C, lupus,
inhalation anthrax and cancer.
Company Official Website: http://www.hgsi.com
5
NOTIFICATION
The Profit-Taker Copyright 1978, 1980,1986, 2009
All rights reserved
Permission granted for personal and educational use only. .
Any unauthorized fund management and/or investment newsletter advice or advisory
service utilizing this intellectual property/concept as their own will constitute an
infringement of this copyright.
All rights are reserved to take any action available to recoup all resulting financial
proceeds and damages therefrom awarded by the appropriate court in breach of this
copyright.
DISCLAIMER
This game or website is not an endorsement of any security.
Information contained in this Website and attachments is of a general nature only and is
not intended to constitute advice for any specific situation. The terms of referral bonuses
may vary and are only applicable in the states and provinces for which they are approved.
Advice from a suitably qualified professional should always be sought in relation to any
particular matter or circumstance.
The Profit-Taker Copyright 1978, 1980,1986, 2009
All rights reserved
Permission granted for personal and educational use only. .
Any unauthorized fund management and/or investment newsletter advice or advisory
service utilizing this intellectual property/concept as their own will constitute an
infringement of this copyright.
All rights are reserved to take any action available to recoup all resulting financial
proceeds and damages therefrom awarded by the appropriate court in breach of this
copyright.
DISCLAIMER
This game or website is not an endorsement of any security.
Information contained in this Website and attachments is of a general nature only and is
not intended to constitute advice for any specific situation. The terms of referral bonuses
may vary and are only applicable in the states and provinces for which they are approved.
Advice from a suitably qualified professional should always be sought in relation to any
particular matter or circumstance.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|